Top 20 Lung Cancer Drugs Market Analysis and Segment Forecasts to 2030

Published Date: May, 2025
Base Year for Estimate:
Report ID: GVR-MT-100309
Format: Electronic (PDF)
Historical Data:
Number of Pages: 150

Market Segmentation

Top 20 Lung Cancer Drugs Market Product Outlook (Revenue, USD Million, 2018 - 2030)
- Tecentriq
- Keytruda
- Avastin
- Tarceva
- Gilotrif
- Iressa
- Tagrisso
- Vizimpro
- Imfinzi
- Enhertu
- Opdivo
- Yervoy
- Alecensa
- Alunbrig
- Lorbrena
- Cosela
- Tabrecta
- Lumakras
- Libyato
- Retevmo
Top 20 Lung Cancer Drugs Market Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Top 20 Lung Cancer Drugs Market, by Product
    - Tecentriq
    - Keytruda
    - Avastin
    - Tarceva
    - Gilotrif
    - Iressa
    - Tagrisso
    - Vizimpro
    - Imfinzi
    - Enhertu
    - Opdivo
    - Yervoy
    - Alecensa
    - Alunbrig
    - Lorbrena
    - Cosela
    - Tabrecta
    - Lumakras
    - Libyato
    - Retevmo
  - U.S.
    - U.S. Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
  - Mexico
    - Mexico Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
- Europe
  - Europe Top 20 Lung Cancer Drugs Market, by Product
    - Tecentriq
    - Keytruda
    - Avastin
    - Tarceva
    - Gilotrif
    - Iressa
    - Tagrisso
    - Vizimpro
    - Imfinzi
    - Enhertu
    - Opdivo
    - Yervoy
    - Alecensa
    - Alunbrig
    - Lorbrena
    - Cosela
    - Tabrecta
    - Lumakras
    - Libyato
    - Retevmo
  - UK
    - UK Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
  - Germany
    - Germany Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
  - France
    - France Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
  - Italy
    - Italy Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
  - Spain
    - Spain Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
  - Denmark
    - Denmark Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
  - Sweden
    - Sweden Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
  - Norway
    - Norway Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
- Asia Pacific
  - Asia Pacific Top 20 Lung Cancer Drugs Market, by Product
    - Tecentriq
    - Keytruda
    - Avastin
    - Tarceva
    - Gilotrif
    - Iressa
    - Tagrisso
    - Vizimpro
    - Imfinzi
    - Enhertu
    - Opdivo
    - Yervoy
    - Alecensa
    - Alunbrig
    - Lorbrena
    - Cosela
    - Tabrecta
    - Lumakras
    - Libyato
    - Retevmo
  - Japan
    - Japan Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
  - China
    - China Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
  - India
    - India Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
  - Australia
    - Australia Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
  - South Korea
    - South Korea Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
  - Thailand
    - Thailand Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
- Latin America
  - Latin America Top 20 Lung Cancer Drugs Market, by Product
    - Tecentriq
    - Keytruda
    - Avastin
    - Tarceva
    - Gilotrif
    - Iressa
    - Tagrisso
    - Vizimpro
    - Imfinzi
    - Enhertu
    - Opdivo
    - Yervoy
    - Alecensa
    - Alunbrig
    - Lorbrena
    - Cosela
    - Tabrecta
    - Lumakras
    - Libyato
    - Retevmo
  - Brazil
    - Brazil Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
  - Argentina
    - Argentina Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
- Middle East & Africa
  - Middle East & Africa Top 20 Lung Cancer Drugs Market, by Product
    - Tecentriq
    - Keytruda
    - Avastin
    - Tarceva
    - Gilotrif
    - Iressa
    - Tagrisso
    - Vizimpro
    - Imfinzi
    - Enhertu
    - Opdivo
    - Yervoy
    - Alecensa
    - Alunbrig
    - Lorbrena
    - Cosela
    - Tabrecta
    - Lumakras
    - Libyato
    - Retevmo
  - South Africa
    - South Africa Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
  - Saudi Arabia
    - Saudi Arabia Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
  - UAE
    - UAE Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo
  - Kuwait
    - Kuwai Top 20 Lung Cancer Drugs Market, by Product
      - Tecentriq
      - Keytruda
      - Avastin
      - Tarceva
      - Gilotrif
      - Iressa
      - Tagrisso
      - Vizimpro
      - Imfinzi
      - Enhertu
      - Opdivo
      - Yervoy
      - Alecensa
      - Alunbrig
      - Lorbrena
      - Cosela
      - Tabrecta
      - Lumakras
      - Libyato
      - Retevmo

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.